Metabolic disorders in patients with psoriasis and psoriatic arthritis

被引：93

作者：

Mallbris L. ^{[1
]}

Ritchlin C.T. ^{[1
]}

Ståhle M. ^{[1
]}

机构：

[1] Department of Medicine, Dermatology Unit, Karolinska Institutet, 171 76, Stockholm

来源：

Current Rheumatology Reports | 2006年 / 8卷 / 5期

关键词：

Obesity; Metabolic Syndrome; Psoriasis; Cigarette Smoking; Dermatol;

D O I：

10.1007/s11926-006-0065-8

中图分类号：

学科分类号：

摘要：

Psoriasis is one of the common complex disorders in Western world, affecting 2% to 3% of the population. Recent studies indicate that psoriasis is associated with an increased risk of comorbidity and mortality compared to the general population. It appears that patients with psoriasis have a higher prevalence of metabolic disorders such as diabetes, hypertension, obesity, and hyperlipidemia, as well as a higher frequency of cigarette smoking. These concomitant diseases can complicate the treatment of psoriasis. Even though the etiology of these associations is elusive, physicians should be aware of them and take active steps to reduce the risk profiles of patients with psoriasis and psoriatic arthritis, in order to lessen mortality and comorbidity. Copyright © 2006 by Current Science Inc.

引用

页码：355 / 363

页数：8

共 62 条

[1]

Raychaudhuri S.P., Farber E.M., The prevalence of psoriasis in the world, J Eur Acad Dermatol Venereol, 15, pp. 16-17, (2001)

[2]

Gladman D.D., Antoni C., Mease P., Et al., Psoriatic arthritis: Epidemiology, clinical features, course, and outcome, Ann Rheum Dis, 64, SUPPL. 2, (2005)

[3]

Capon F., Trembath R.C., Barker J.N., An update on the genetics of psoriasis, Dermatol Clin, 22, pp. 339-347, (2004)

[4]

Nair R.P., Stuart P.E., Nistor I., Et al., Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene, Am J Hum Genet, 78, pp. 827-851, (2006)

[5]

Mallon E., Bunce M., Savoie H., Et al., HLA-C and guttate psoriasis, Br J Dermatol, 143, pp. 1177-1182, (2000)

[6]

Lindegard B., Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes, Dermatologica, 172, pp. 298-304, (1986)

[7]

Henseler T., Christophers E., Disease concomitance in psoriasis, J Am Acad Dermatol, 32, pp. 982-986, (1995)

[8]

Lopez A.D., Mathers C.D., Ezzati M., Et al., Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data, Lancet, 367, pp. 1747-1757, (2006)

[9]

Arnett D.K., McGovern P.G., Jacobs Jr. D.R., Et al., Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): The Minnesota Heart Survey, Am J Epidemiol, 156, pp. 929-935, (2002)

[10]

Willerson J.T., Ridker P.M., Inflammation as a cardiovascular risk factor, Circulation, 109, (2004)

← 1 2 3 4 5 6 7 →